Concepedia

Shu Cao

SC

Statistics

Publications

51

Citations

1.7K

H-Index

26

Active since

2000

Affiliations

University of Southern California(Current)

USC Norris Comprehensive Cancer Center

Azienda Ospedaliera Universitaria Pisana

Istituto Oncologico Veneto

Istituti di Ricovero e Cura a Carattere Scientifico

Shu Cao is an author at University of Southern California specializing in medicine, oncology, and colorectal cancer.

ORCID

Publications per year

2000–2023

51

Publications

51

Phase 2a randomized, placebo-controlled study of anti–IL-33 in peanut allergy

R. Sharon Chinthrajah, Shu Cao, Cherie Liu et al. · JCI Insight · 2019 · 189 citations · Full text

, , +13

Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition via suppression of the Notch signaling pathway

Mingde Zang, Lei Hu, Zhiyuan Fan et al. · Journal of Translational Medicine · 2017 · 111 citations · Full text

, , +17

Prevention of diabetic foot complications

Aziz Nather, Shu Cao, JLW Chen · Singapore Medical Journal · 2018 · 97 citations · Full text

, , +14

Overexpression of miR-214-3p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG-BP1

Pornima Phatak, Kimberly A. Byrnes, Dina Mansour et al. · Oncogene · 2015 · 93 citations

, , +11

Asthma phenotypes, associated comorbidities, and long‐term symptoms in COVID‐19

L. Eggert, Ziyuan He, William Collins et al. · Allergy · 2021 · 74 citations · Full text

, , +14

1–5 of 51